FDA wasn't part of the Brazil file -- no eIND or FDA audit, so that data is not likely useable in the U.S. The Meta analysis would be combining CD12 with CD20. Thye have to provide an analytics plan for approval prior to unblinding CD20 -- but CD12 was two injectable doses that probably won't add positively to the CD20 up t0 4 IV doses.
CYTODYN making strides according to who? Nader, the pathological liar? Show any third party verification on any front. 4 Patients enrollment in Brazil?
News 
Market Data 
Discover 
